Oncology News

National Cancer Institute Director Monica M. Bertagnolli, MD, FACS, FASCO, announced that she has been diagnosed with early-stage hormone receptor-positive, HER2-negative breast cancer.

In this episode, host Shikha Jain, MD, speaks with Edith Perez, MD, about equity initiatives in health care organizations, the evolution of precision oncology and more.

In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition.

High allostatic load indicating lifelong stress was linked to a 106% increased risk for cancer-associated death among young Black individuals and a 95% increased risk among young white individuals, according to a recent study.

The commercial insurance costs for breast reconstruction vary greatly across the United States, with less competitive markets and large, for-profit and nonsafety-net hospitals seeing the highest rates.

In this edition, alcohol consumption increases cancer risk, medical marijuana associated with lower rates of opioid prescriptions, lifelong stress increases risk for cancer mortality, and more.

In this episode of Meeting Mic, we bring you the highlights and insights from the SABCS 2022, as well as Healio’s top headlines from the meeting.

In this episode, FDA grants fast track designation to REM-001; practice-changing treatment advances continue; proton partial breast radiotherapy appears effective and more.

Compared with systematic biopsy, MRI-directed targeted biopsy reduces the risk of overdiagnosis of prostate cancer for men with elevated prostate-specific antigen levels, according to researchers.

Tamoxifen use in the treatment of breast cancer was associated with greater risks for endometrial cancer, hyperplasia and polyps, as well as other uterine cancers among premenopausal women in Korea, according to study data.